Perspectives for the management of febrile neutropenic patients with cancer in the 21st century

Cited in:

CrossRef

This article has been cited by:

1. 1
   Keisuke Sunakawa, Ichiro Tsukimoto, Yukiko Tsunematsu, Masatada Honda, Naoichi Iwai, Takashi Maniwa, Hisamatsu Haigo, Kota Suzuki, Takeshi Mori, Evaluation of the safety and efficacy of liposomal amphotericin B (L-AMB) in children, Journal of Infection and Chemotherapy, 2012,

   CrossRef

2. 2
   Maria N. Gamaletsou, Nikolaos V. Sipsas, Dimitrios P. Kontoyiannis, Micafungin in haematology, Mycoses, 2012, 55,

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(131K)
   • References
3. 3
   Cheol-In Kang, Jae-Hoon Song, Kwan Soo Ko, Doo Ryeon Chung, Kyong Ran Peck, Clinical features and outcomes of Staphylococcus aureus infections in non-neutropenic cancer patients, Supportive Care in Cancer, 2011, 20, 3, 483

   CrossRef

4. 4
   G. Samonis, E. Koutsounaki, D. E. Karageorgopoulos, P. Mitsikostas, C. Kalpadaki, V. Bozionelou, I. Bompolaki, J. Sgouros, V. Taktikou, M. E. Falagas, Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study, European Journal of Clinical Microbiology & Infectious Diseases, 2011,

   CrossRef

5. 5
   A Carmona-Bayonas, J Gómez, E González-Billalabeitia, M Canteras, A Navarrete, M L Gonzálvez, V Vicente, F Ayala de la Peña, Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients, British Journal of Cancer, 2011, 105, 5, 612

   CrossRef

6. 6
   Emmanouil Saloustros, Kostas Tryfonidis, Vassilis Georgoulias, Prophylactic and therapeutic strategies in chemotherapy-induced neutropenia, Expert Opinion on Pharmacotherapy, 2011, 12, 6, 851

   CrossRef

7. 7
   Nicholas J. Jouriles, Emergency Medicine Secrets, 2011,

   CrossRef

8. 8
   Michaela Semeraro, Caroline Thomée, Estelle Rolland, Marie Cecile Le Deley, David Rosselini, Frederic Troalen, Loredana Amoroso, Marie Dubrel, Olivier Hartmann, A predictor of unfavourable outcome in neutropenic paediatric patients presenting with fever of unknown origin, Pediatric Blood & Cancer, 2010, 54, 2

   Direct Link:

   • Abstract
   • Full Article (HTML)
   • PDF(113K)
   • References
9. 9
   Johan A. Maertens, Luis Madero, Anne F. Reilly, Thomas Lehrnbecher, Andreas H. Groll, Hasan S. Jafri, Michael Green, Joseph J. Nania, Michael R. Bourque, Beth Ann Wise, Kim M. Strohmaier, Arlene F. Taylor, Nicholas A. Kartsonis, Joseph W. Chow, Carola A. S. Arndt, Ben E. dePauw, Thomas J. Walsh, A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia, The Pediatric Infectious Disease Journal, 2010, 29, 5, 415

   CrossRef

10. 10
    Heather McKenzie, Lillian Hayes, Kathryn White, Keith Cox, Judith Fethney, Maureen Boughton, Jo Dunn, Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study, Supportive Care in Cancer, 2010, 19, 7, 963

    CrossRef

11. 11
    G. Pongas, G. Hamilos, K. V. Rolston, Dimitrios P. Kontoyiannis, Formal adult infectious disease specialist consultations in the outpatient setting at a comprehensive cancer center (1998–2008): Diverse and impactful, Supportive Care in Cancer, 2010, 20, 2, 261

    CrossRef

12. 12
    Christopher R. Friese, Jeffrey H. Silber, Linda H. Aiken, National Cancer Institute Cancer Center Designation and 30-Day Mortality for Hospitalized, Immunocompromised Cancer Patients, Cancer Investigation, 2010, 28, 7, 751

    CrossRef

13. 13
    C. Straka, M. Sandherr, H. Salwender, H. Wandt, B. Metzner, K. Hubel, G. Silling, M. Hentrich, D. Franke, R. Schwerdtfeger, M. Freund, O. Sezer, A. Giagounidis, G. Ehninger, W. Grimminger, A. Engert, G. Schlimok, C. Scheid, P. Hellmann, H. Heinisch, H. Einsele, A. Hinke, B. Emmerich, Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapy, Blood, 2010, 117, 7, 2121

    CrossRef

14. 14
    Tracy Lemonovich, David A. Bobak, Robert A. Salata, Andreoli and Carpenter's Cecil Essentials of Medicine, 2010,

    CrossRef

15. 15
    Rocio Parody, Rodrigo Martino, Ferran Sánchez, Maricel Subirá, Alberto Hidalgo, Jorge Sierra, Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes, American Journal of Hematology, 2009, 84, 9

    Direct Link:

    • Abstract
    • PDF(233K)
    • References
16. 16
    María del Carmen Gayol, Albert Font, Irma Casas, Oriol Estrada, M. Jesús Domínguez, M. Luisa Pedro-Botet, Utilidad de la escala de MASCC en el tratamiento de la neutropenia febril inducida por quimioterapia en pacientes con neoplasia sólida, Medicina Clínica, 2009, 133, 8, 296

    CrossRef

17. 17
    S. Sahali, N. Noël, J. Ghosn, Antibioticoprofilassi delle infezioni batteriche, EMC - AKOS - Trattato di Medicina, 2008, 10, 2, 1

    CrossRef

18. 18
    S. Sahali, N. Noël, J. Ghosn, Antibioticoprofilaxis de las infecciones bacterianas, EMC - Tratado de Medicina, 2008, 12, 2, 1

    CrossRef

19. 19
    Patrick G. Morris, Tidi Hassan, Mairead McNamara, Astrid Hassan, Rebecca Wiig, Liam Grogan, Oscar S. Breathnach, Edmond Smyth, Hilary Humphreys, Emergence of MRSA in positive blood cultures from patients with febrile neutropenia—a cause for concern, Supportive Care in Cancer, 2008, 16, 9, 1085

    CrossRef

20. 20
    Yiannis L. Katsogridakis, Kristine L. Cieslak, Empiric Antibiotics for the Complex Febrile Child: When, Why, and What to Use, Clinical Pediatric Emergency Medicine, 2008, 9, 4, 258

    CrossRef

21. 21
    Catherine D. Cooksley, Elenir B. C. Avritscher, Kenneth V. Rolston, Linda S. Elting, Hospitalizations for infection in cancer patients: impact of an aging population, Supportive Care in Cancer, 2008, 17, 5, 547

    CrossRef

22. 22
    Hans Jürgen Dornbusch, Volker Strenger, Petra Sovinz, Herwig Lackner, Wolfgang Schwinger, Reinhold Kerbl, Christian Urban, Non-infectious causes of elevated procalcitonin and C-reactive protein serum levels in pediatric patients with hematologic and oncologic disorders, Supportive Care in Cancer, 2008, 16, 9, 1035

    CrossRef

23. 23
    Aihua Wang, Shaozhen Fan, Yonghong Yang, Xuzhuang Shen, Nosocomial Infections Among Pediatric Hematology Patients, Journal of Pediatric Hematology/Oncology, 2008, 30, 9, 674

    CrossRef

24. 24
    J. Zuckermann, L. B. Moreira, P. Stoll, L. M. Moreira, R. S. Kuchenbecker, C. A. Polanczyk, Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes, Annals of Hematology, 2007, 87, 2, 139

    CrossRef

25. 25
    Abhijit M. Bal, Ian M. Gould, Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia, International Journal of Antimicrobial Agents, 2007, 29, 5, 501

    CrossRef

26. 26
    Anastasia Antoniadou, Helen Giamarellou, Fever of Unknown Origin in Febrile Leukopenia, Infectious Disease Clinics of North America, 2007, 21, 4, 1055

    CrossRef

27. 27
    Y. Ofran, I. Avivi, A. Oliven, I. Oren, T. Zuckerman, L. Bonstein, J. M. Rowe, E. J. Dann, Granulocyte transfusions for neutropenic patients with life-threatening infections: a single centre experience in 47 patients, who received 348 granulocyte transfusions, Vox Sanguinis, 2007, 93, 4

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(167K)
    • References
28. 28
    Luciano Souza Viana, José Carlos Serufo, Manoel Otávio Costa Rocha, Renato Nogueira Costa, Roberto Carlos Duarte, Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients, Supportive Care in Cancer, 2007, 16, 7, 841

    CrossRef

29. 29
    Christopher R. Friese, Prevention of Infection in Patients With Cancer, Seminars in Oncology Nursing, 2007, 23, 3, 174

    CrossRef

30. 30
    C. Rieger, P. Herzog, R. Eibel, M. Fiegl, H. Ostermann, Pulmonary MRI—a new approach for the evaluation of febrile neutropenic patients with malignancies, Supportive Care in Cancer, 2007, 16, 6, 599

    CrossRef

31. 31
    David A. Hasselbacher, Scott Morehead, Dianne Wilson, Pulmonary Mucormycosis: Empiricism backfires, Respiratory Medicine Extra, 2007, 3, 2, 86

    CrossRef

32. 32
    Anastasia Antoniadou, Helen Giamarellou, Fever of Unknown Origin, 2007,

    CrossRef

33. 33
    V. Ozkocaman, T. Ozcelik, R. Ali, F. Ozkalemkas, A. Ozkan, C. Ozakin, H. Akalin, A. Ursavas, F. Coskun, B. Ener, A. Tunali, Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes, Journal of Hospital Infection, 2006, 64, 2, 169

    CrossRef

34. 34
    N. V. Sipsas, D. P. Kontoyiannis, Clinical Issues Regarding Relapsing Aspergillosis and the Efficacy of Secondary Antifungal Prophylaxis in Patients with Hematological Malignancies, Clinical Infectious Diseases, 2006, 42, 11, 1584

    CrossRef

35. 35
    Thorvardur R. Halfdanarson, William J. Hogan, Timothy J. Moynihan, Oncologic Emergencies: Diagnosis and Treatment, Mayo Clinic Proceedings, 2006, 81, 6, 835

    CrossRef

36. 36
    C Harter, B Schulze, H Goldschmidt, A Benner, H K Geiss, T Hoppe-Tichy, A D Ho, G Egerer, Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial, Bone Marrow Transplantation, 2006, 37, 4, 373

    CrossRef

37. 37
    W. V. Kern, Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia, Clinical Infectious Diseases, 2006, 42, 4, 533

    CrossRef

38. 38
    Maurie Markman, Supportive care, Update on Cancer Therapeutics, 2006, 1, 1, 85

    CrossRef

39. 39
    Julia C. Chisholm, Rachel Dommett, The evolution towards ambulatory and day-case management of febrile neutropenia, British Journal of Haematology, 2006, 135, 1

    Direct Link:

    • Abstract
    • Full Article (HTML)
    • PDF(526K)
    • References
40. 40
    Dominique Navas, Jocelyne Caillon, Eric Batard, Philippe Le Conte, Marie-France Kergueris, Philippe Moreau, Gilles Potel, Trough serum concentrations of β-lactam antibiotics in cancer patients: inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of β-lactams, International Journal of Antimicrobial Agents, 2006, 27, 2, 102

    CrossRef

41. 41
    Joaquín Díaz-Mediavilla, Manuel Lizasoain, Epidemiología de las infecciones en el paciente neutropénico, Enfermedades Infecciosas y Microbiología Clínica, 2005, 23, 7

    CrossRef

42. 42
    Enric Carreras, Josep Mensa, Neutropenia febril: pasado, presente y futuro, Enfermedades Infecciosas y Microbiología Clínica, 2005, 23, 2

    CrossRef

43. 43
    Alfonso J. Alanis, Resistance to Antibiotics: Are We in the Post-Antibiotic Era?, Archives of Medical Research, 2005, 36, 6, 697

    CrossRef